Long-term use of proton pump inhibitors (PPIs) is associated with an increased risk of type 2 diabetes

Affiliations

• ¹ Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany Sven.Loosen@med.uni-duesseldorf.de.
• ² Epidemiology, IQVIA, Frankfurt, Germany.
• ³ Department of Internal Medicine, Christian Albrechts University of Kiel, Kiel, Germany.
• ⁴ Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.